AkaRx
Paramus
About AkaRx
AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $21.1M
- Funding stage: M&A
- Last round: Series Unknown (Jul 2007)
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/akarx-2061351 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.